It may not have been pretty, but Regulus Therapeutics ($RGLS) raised close to $81 million from its recent IPO and some related transactions. And the company did it with a big assist from some major league partners in the biopharma industry. Report
| Monday, September 14th | 1pm ET / 10am PT | Sponsored by: Elsevier
This webinar will feature experts in drug development, regulatory processes and managed care who can shed light on the impact of escalating drug prices and provide tips on navigating these challenges. Reserve Your Spot Today!
FiercePharma is the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products. Join 150,000+ pharma industry leaders who get FiercePharma via daily email. Click here to get your free weekly email briefing today!